Related Experiment Video
Updated: May 24, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Smoking-related interstitial lung diseases.
1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA. ryu.jay@mayo.edu
Smoking cessation is crucial for managing diffuse lung diseases caused by cigarette smoke. Quitting smoking can lead to disease remission, while medications may help progressive cases.
Area of Science:
- Pulmonology
- Toxicology
Background:
- Cigarette smoke is a major cause of diffuse interstitial and bronchiolar lung diseases.
- Most individuals with these conditions are cigarette smokers.
Purpose of the Study:
- To highlight the importance of smoking cessation in managing smoking-related lung diseases.
- To discuss the potential role of pharmacotherapy in progressive cases.
Main Methods:
- Literature review on smoking-related lung diseases.
- Analysis of treatment outcomes based on smoking status.
- Evaluation of pharmacotherapy efficacy.
Main Results:
- Smoking cessation is effective in inducing remission of diffuse lung diseases.
- Smoking is the primary risk factor for these conditions.
- Pharmacotherapy's role is uncertain but may benefit progressive disease.
Conclusions:
- Smoking cessation should be central to managing all smokers with diffuse lung diseases.
- Pharmacotherapy may be considered for progressive smoking-related interstitial lung diseases.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
